Pathways of impending disease flare in African-American systemic lupus erythematosus patients.

about

Biomarkers in connective tissue diseases.Acute vision loss in systemic lupus erythematosus: bilateral combined retinal artery and vein occlusion as a catastrophic form of clinical flare.

P2860

Q47314399-4D541E05-1F2A-45EC-9A20-B57D12739FCF Q47655910-27CD7B64-F629-4C17-A441-94AB283E2421

P2860

Pathways of impending disease flare in African-American systemic lupus erythematosus patients.

Item

http://www.wikidata.org/entity/Q50910971

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pathways of impending disease ...... lupus erythematosus patients.

@en

Pathways of impending disease ...... lupus erythematosus patients.

@nl

type

Item

label

Pathways of impending disease ...... lupus erythematosus patients.

@en

Pathways of impending disease ...... lupus erythematosus patients.

@nl

prefLabel

Pathways of impending disease ...... lupus erythematosus patients.

@en

Pathways of impending disease ...... lupus erythematosus patients.

@nl

P1476

Pathways of impending disease ...... lupus erythematosus patients.

@en

P2093

Evan S Vista

http://www.w3.org/2001/XMLSchema#string

Joan T Merrill

http://www.w3.org/2001/XMLSchema#string

Virginia C Roberts

http://www.w3.org/2001/XMLSchema#string

P2860

Profile of atacicept and its potential in the treatment of systemic lupus erythematosus

Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus

The balance between IL-1 and IL-1Ra in disease

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort

Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.

The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort.

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus

P304

70-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JAUT.2016.12.005

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Melissa E Munroe

Joel M Guthridge

Judith A. James

P577

2017-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28162788

http://www.w3.org/2001/XMLSchema#string

P932

5340190

http://www.w3.org/2001/XMLSchema#string

Pathways of impending disease flare in African-American systemic lupus erythematosus patients.

about

P2860

P2860

Pathways of impending disease flare in African-American systemic lupus erythematosus patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932